Search results for "Hydroxymethyl"

showing 10 items of 313 documents

Die kolorimetrische bestimmung von konstitutions und molekulareinheitlichen phenol-formaldehyd-kondensaten in methanolischer lösung mit FeCl3

1961

Phenol-Formaldehyd-Kondensate, die bestimmte Atomgruppierungen (vor allem zur phenolischen Gruppe ortho-standige Hydroxymethylgruppen) besitzen, geben in methanolischer Losung mit FeCl3 · 6H2O eine Farbreaktion. Es werden die Bedingungen mitgeteilt, unter denen die Extinktion der Farbreaktion reproduzierbar und innerhalb der Meszeit konstant ist. Bei Eisen(III)-chlorid-Konzentrationen von 0,24 bis 0,6 [Mol/1] ist die Extinktion linear abhangig von der Konzentration der Phenol-Formaldehyd-Kondensate. Die Extinktionen von Gemischen derartiger Kondensate verhalten sich additiv. Die analytische Anwendbarkeit der Farbreaktion wird erortert. In methanolic solution phenol-formaldehyde condensates …

Ortho positionchemistry.chemical_compoundChemistryColor reactionPolymer chemistryFormaldehydePhenolHydroxymethylDie Makromolekulare Chemie
researchProduct

Chemical transformations of glucose in solutions for peritoneal dialysis after sterilization and during storage

2018

The objective of this work was to estimate glucose degradation products (GDPs) in solutions for peritoneal dialysis (PD) including glucose and sodium lactate based on the change of pH and absorption of ultraviolet (UV) light. Spectrophotometric and pH-metric methods were used to measure glucose degradation and transformation of GDPs in laboratory-made solutions after heat sterilization and during storage. Mechanism of transformations of GDPs in the sterilized solutions for PD during storage and spectral characteristic of 5-HMF were studied. Common features for all the batches of the tested solutions for PD after heat sterilization were a reduce in pH, increase in the absorbance in the range…

Pharmacology5-hydroxymethylfurfuralmedicine.medical_specialtybusiness.industry3medicine.medical_treatmentPharmaceutical ScienceSterilization (microbiology)4-dideoxyglucosone-3-eneSurgeryPeritoneal dialysisperitoneal dialysismedicinebusinessActa Poloniae Pharmaceutica
researchProduct

Statins and angiogenesis in non-cardiovascular diseases.

2022

Statins inhibit HMG-CoA reductase by competitively inhibiting the active site of the enzyme, thus preventing cholesterol synthesis and reducing the risk of developing cardiovascular disease. Many pleiotropic effects of statins have been demonstrated that can be either related or unrelated to their cholesterol-lowering ability. Among these effects are their proangiogenic and antiangiogenic properties that could offer new therapeutic applications. In this regard, pro- and anti-angiogenic properties of statins have been shown to be dose dependent. Statins also appear to have a variety of non-cardiovascular angiogenic effects in many diseases, some examples being ocular disease, brain disease, …

PharmacologyCholesterolNeovascularization PathologicCardiovascular DiseasesNeoplasmsDrug DiscoveryHumansHydroxymethylglutaryl-CoA Reductase InhibitorsAngiogenesis Bone disease Brain disease Cancer Cardiovascular Diabetes Ocular disease Preeclampsia Statins VascularizationDrug discovery today
researchProduct

Statins and new-onset diabetes

2013

Statins are highly efficacious lipid modifying agents that reduce the risk for cardiovascular (CV) events in both primary and secondary prevention settings. However, statins affect molecular mechanisms which adversely impact on insulin sensitivity and β-cell function, thereby increasing risk for new onset diabetes mellitus (NOD). Defining the mechanisms involved is the focus of considerable current investigation. The statins reduce the risk for CV events in normoglycemic patients as well as in those with diabetes mellitus (DM) and their benefits outweigh the risk of inducing NOD. We review the clinical evidence for NOD with statin treatment, as well as the potential mechanisms involved. Our…

PharmacologySecondary preventionLIPID MODIFYING AGENTSbusiness.industrynutritional and metabolic diseasesInsulin sensitivityNodPharmacologyStatin treatmentBioinformaticsmedicine.diseaseRisk AssessmentPrimary PreventionDiabetes Mellitus Type 2New onset diabetesCardiovascular DiseasesDiabetes mellitusDrug DiscoverySecondary PreventionmedicineHumansHydroxymethylglutaryl-CoA Reductase InhibitorsRisk assessmentbusinessnew-onset diabetes mellitus statin cardiovascular events insulin sensitivity primary prevention secondary prevention
researchProduct

Editorial: Ischemic Stroke Prevention

2014

Pharmacologymedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryStroke ischemic PreventionBrain IschemiaStrokeInternal medicineIschemic strokemedicineCardiologyAnimalsHumansHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsCurrent Vascular Pharmacology
researchProduct

Selective Photocatalytic Oxidation of 5-Hydroxymethylfurfural to 2,5-Furandicarboxaldehyde by Polymeric C3N4-H2O2 Adduct

2018

Selective Photocatalytic Oxidation of 5-Hydroxymethylfurfural to 2,5-Furandicarboxaldehyde by Polymeric C3N4-H2O2 Adduct

Photocatalytic oxidation of 5-Hydroxymethylfurfural 25-Furandicarboxaldehyde C3N4-H2O2Settore CHIM/07 - Fondamenti Chimici Delle Tecnologie
researchProduct

Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

2017

In recent years, there has been growing interest in the possible use of nutraceuticals to improve and optimize dyslipidemia control and therapy. Based on the data from available studies, nutraceuticals might help patients obtain theraputic lipid goals and reduce cardiovascular residual risk. Some nutraceuticals have essential lipid-lowering properties confirmed in studies; some might also have possible positive effects on nonlipid cardiovascular risk factors and have been shown to improve early markers of vascular health such as endothelial function and pulse wave velocity. However, the clinical evidence supporting the use of a single lipid-lowering nutraceutical or a combination of them is…

PhytochemicalsMedicine (miscellaneous)030204 cardiovascular system & hematologyPharmacologyIntestinal absorption0302 clinical medicineRisk FactorsDrug Interactions030212 general & internal medicineRandomized Controlled Trials as TopicNutrition and DieteticsEvidence-Based MedicineOrvostudományok3. Good healthObservational Studies as TopicLiverCardiovascular DiseasesFatty Acids Unsaturatedlipids (amino acids peptides and proteins)nutraceuticalposition papermedicine.medical_specialtyStatinCombination therapymedicine.drug_classKlinikai orvostudományok03 medical and health sciencesMeta-Analysis as TopiclipidmedicineHumansIntensive care medicineLife StyleTriglyceridesDyslipidemiasbusiness.industryProbioticsdyslipidemiaCholesterol HDLEvidence-based medicineCholesterol LDLmedicine.diseaseResidual riskIntestinal AbsorptionrecommendationsDietary SupplementsPosition paperObservational Studies as TopicHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessDyslipidemia
researchProduct

Rigid Hyperbranched Polycarbonate Polyols from CO2 and Cyclohexene-Based Epoxides

2017

Hyperbranched, multifunctional polycarbonate polyols based on CO2, cyclohexene oxide (CHO), and the “inimer” (initiator–monomer) (4-hydroxymethyl)cyclohexene oxide (HCHO) were prepared in one-pot syntheses. The related linear poly(hydroxymethyl cyclohexene carbonate) structures based on protected HCHO and postpolymerization deprotection were also synthesized as model compounds. The content of hydroxyl functionalities was adjustable for both linear and hyperbranched terpolymer systems. All CO2/epoxide polymerizations were catalyzed by the (R,R)-(salcy)-Co(III)Cl complex. The polycarbonates obtained were comprehensively investigated using various 1D and 2D NMR techniques, SEC, FT-IR, UV–vis s…

Polymers and PlasticsIntrinsic viscosityOrganic ChemistryDispersityCyclohexeneEpoxide02 engineering and technology010402 general chemistry021001 nanoscience & nanotechnology01 natural sciences0104 chemical sciencesInorganic Chemistrychemistry.chemical_compoundchemistryvisual_artPolymer chemistryMaterials Chemistryvisual_art.visual_art_mediumCopolymerOrganic chemistryHydroxymethylPolycarbonate0210 nano-technologyCyclohexene oxideMacromolecules
researchProduct

Cationic Copolymerization of 3,3-Bis(hydroxymethyl)oxetane and Glycidol: Biocompatible Hyperbranched Polyether Polyols with High Content of Primary H…

2015

The cationic ring-opening copolymerization of 3,3-bis(hydroxymethyl)oxetane (BHMO) with glycidol using different comonomer ratios (BHMO content from 25 to 90%) and BF3OEt2 as an initiator has been studied. Apparent molecular weights of the resulting hyperbranched polyether copolymers ranged from 1400 to 3300 g mol(-1) (PDI: 1.21-1.48; method: SEC, linear PEG standards). Incorporation of both comonomers is evidenced by MALDI-TOF mass spectroscopy. All hyperbranched polyether polyols with high content of primary hydroxyl groups portray good solubility in water, which correlates with an increasing content of glycerol units. Detailed NMR characterization was employed to elucidate the copolymer …

Polymers and PlasticsPropanolsProton Magnetic Resonance SpectroscopyComonomerGlycidolCationic polymerizationBiocompatible MaterialsBioengineeringOxetanePolymerizationBiomaterialschemistry.chemical_compoundchemistryPolymerizationEthers CyclicCationsSpectrometry Mass Matrix-Assisted Laser Desorption-IonizationPolymer chemistryMaterials ChemistryCopolymerEpoxy CompoundsOrganic chemistryHydroxymethylCarbon-13 Magnetic Resonance SpectroscopySolubilityBiomacromolecules
researchProduct

Determination of tocopherols in vegetable oils by CEC using methacrylate ester-based monolithic columns

2007

The separation and determination of tocopherols (Ts) in vegetable oils by CEC using methacrylate ester-based monolithic columns has been developed. The effects of pore size of the monolithic columns were studied, and the composition of mobile phase was optimized. The optimal pore size of the monolith was obtained with 12 wt% 1,4-butanediol in the polymerization mixture. Excellent resolution between tocopherols was achieved within 10 min analysis time with a 99:1 v/v MeOH-aqueous buffer containing 5 mM tris(hydroxymethyl)aminomethane at pH 8.0. The LODs were lower than 2.3 microg/mL, and interday and column-to-column reproducibilities at 25 microg/mL were better than 5.6%. Using a 93:7 v/v M…

Pore sizeTrisgeographygeography.geographical_feature_categoryChromatographyResolution (mass spectrometry)TocotrienolsClinical BiochemistryTocopherolsPalm OilMethacrylateBiochemistryAnalytical Chemistrychemistry.chemical_compoundPolymerizationchemistrySeedsMethacrylatesPlant OilsVitisHydroxymethylComposition (visual arts)MonolithOlive OilChromatography Micellar Electrokinetic CapillaryELECTROPHORESIS
researchProduct